Acadia Pharmaceuticals Stock
Acadia Pharmaceuticals Stock
Acadia Pharmaceuticals gained 0.330% compared to yesterday.
The stock is one of the favorites of our community with 28 Buy predictions and 1 Sell predictions.
With a target price of 31 € there is potential for a 125.62% increase which would mean more than doubling the current price of 13.74 € for Acadia Pharmaceuticals.
Our community identified positive and negative aspects for Acadia Pharmaceuticals stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Acadia Pharmaceuticals stock. On the other hand our users think that "EBIT growth" could be a problem in the future.
Pros and Cons of Acadia Pharmaceuticals in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
S********** s********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Acadia Pharmaceuticals vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals | 0.330% | -3.956% | -14.443% | -36.472% | -52.130% | -20.170% | -39.712% |
Ironwood Pharmaceuticals | 1.720% | -7.200% | -21.088% | -39.896% | -43.137% | -41.117% | - |
Novocure Ltd | 11.220% | 32.158% | 78.326% | -72.485% | 41.786% | -86.061% | - |
Iovance Biotherapeutics Inc. | 1.380% | -7.525% | -11.439% | 38.319% | 20.569% | -29.851% | - |
Comments
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at HC Wainwright from $33.00 to $27.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target lowered by analysts at Citigroup Inc. from $30.19 to $30.00. They now have a "buy" rating on the stock.
Show more
Ratings data for ACAD provided by MarketBeat
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $37.00 price target on the stock.
Show more
Ratings data for ACAD provided by MarketBeat